News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
661,284 Results
Type
Article (54381)
Company Profile (237)
Press Release (606651)
Multimedia
Podcasts (117)
Webinars (21)
Section
Business (179640)
Career Advice (2854)
Deals (32548)
Drug Delivery (125)
Drug Development (80574)
Employer Resources (170)
FDA (15538)
Job Trends (14325)
News (315854)
Policy (31327)
Tag
Academia (2808)
Academic (1)
Accelerated approval (16)
Adcomms (35)
Allergies (125)
Alliances (49708)
ALS (143)
Alzheimer's disease (1631)
Antibody-drug conjugate (ADC) (251)
Approvals (15590)
Artificial intelligence (443)
Autoimmune disease (92)
Automation (27)
Bankruptcy (348)
Best Places to Work (11215)
BIOSECURE Act (22)
Biosimilars (159)
Biotechnology (176)
Bladder cancer (133)
Brain cancer (50)
Breast cancer (499)
Cancer (3967)
Cardiovascular disease (340)
Career advice (2409)
Career pathing (36)
CAR-T (241)
CDC (51)
Cell therapy (655)
Cervical cancer (30)
Clinical research (67530)
Collaboration (1396)
Company closure (4)
Compensation (650)
Complete response letters (56)
COVID-19 (2795)
CRISPR (79)
C-suite (606)
Cystic fibrosis (131)
Data (4692)
Decentralized trials (2)
Denatured (32)
Depression (109)
Diabetes (446)
Diagnostics (6463)
Digital health (33)
Diversity (10)
Diversity, equity & inclusion (43)
Drug discovery (200)
Drug pricing (180)
Drug shortages (30)
Duchenne muscular dystrophy (200)
Earnings (64727)
Editorial (53)
Employer branding (22)
Employer resources (154)
Events (95808)
Executive appointments (974)
FDA (17992)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (6)
Frontotemporal dementia (16)
Funding (1220)
Gene editing (167)
Generative AI (39)
Gene therapy (538)
GLP-1 (959)
Government (4767)
Grass and pollen (8)
Guidances (366)
Healthcare (18102)
HIV (46)
Huntington's disease (40)
IgA nephropathy (64)
Immunology and inflammation (246)
Immuno-oncology (22)
Indications (56)
Infectious disease (3035)
Inflammatory bowel disease (180)
Inflation Reduction Act (15)
Influenza (97)
Intellectual property (194)
Interviews (566)
IPO (14659)
IRA (56)
Job creations (3441)
Job search strategy (1976)
Kidney cancer (17)
Labor market (63)
Layoffs (570)
Leadership (36)
Legal (7081)
Liver cancer (91)
Longevity (12)
Lung cancer (578)
Lymphoma (264)
Machine learning (31)
Management (60)
Manufacturing (616)
MASH (145)
Medical device (12352)
Medtech (12374)
Mergers & acquisitions (18753)
Metabolic disorders (1122)
Multiple sclerosis (139)
NASH (23)
Neurodegenerative disease (227)
Neuropsychiatric disorders (59)
Neuroscience (2654)
NextGen: Class of 2025 (6477)
Non-profit (4508)
Now hiring (54)
Obesity (532)
Opinion (299)
Ovarian cancer (137)
Pain (170)
Pancreatic cancer (172)
Parkinson's disease (233)
Partnered (29)
Patents (412)
Patient recruitment (331)
Peanut (56)
People (57421)
Pharmaceutical (45)
Pharmacy benefit managers (23)
Phase I (21007)
Phase II (29670)
Phase III (22312)
Pipeline (2758)
Policy (281)
Postmarket research (2590)
Preclinical (8785)
Press Release (70)
Prostate cancer (195)
Psychedelics (51)
Radiopharmaceuticals (262)
Rare diseases (666)
Real estate (5575)
Recruiting (74)
Regulatory (23018)
Reports (37)
Research institute (2454)
Resumes & cover letters (436)
Rett syndrome (16)
RNA editing (14)
RSV (70)
Schizophrenia (134)
Series A (205)
Series B (156)
Service/supplier (12)
Sickle cell disease (79)
Special edition (25)
Spinal muscular atrophy (161)
Sponsored (41)
Startups (3565)
State (2)
Stomach cancer (16)
Supply chain (93)
Tariffs (87)
The Weekly (84)
Vaccines (976)
Venture capital (67)
Weight loss (366)
Women's health (48)
Worklife (20)
Date
Today (54)
Last 7 days (638)
Last 30 days (2508)
Last 365 days (29906)
2025 (24921)
2024 (34165)
2023 (38366)
2022 (49305)
2021 (53300)
2020 (51868)
2019 (45321)
2018 (34483)
2017 (31681)
2016 (30469)
2015 (35206)
2014 (28766)
2013 (24772)
2012 (24679)
2011 (25457)
2010 (23243)
Location
Africa (913)
Alabama (70)
Alaska (6)
Arizona (215)
Arkansas (13)
Asia (40556)
Australia (7848)
California (8767)
Canada (2725)
China (896)
Colorado (359)
Connecticut (386)
Delaware (256)
Europe (92402)
Florida (1368)
Georgia (280)
Hawaii (2)
Idaho (58)
Illinois (695)
India (51)
Indiana (446)
Iowa (18)
Japan (328)
Kansas (121)
Kentucky (31)
Louisiana (18)
Maine (65)
Maryland (1193)
Massachusetts (6313)
Michigan (269)
Minnesota (500)
Mississippi (4)
Missouri (107)
Montana (26)
Nebraska (26)
Nevada (106)
New Hampshire (75)
New Jersey (2485)
New Mexico (30)
New York (2432)
North Carolina (1223)
North Dakota (9)
Northern California (4044)
Ohio (267)
Oklahoma (18)
Oregon (36)
Pennsylvania (1788)
Puerto Rico (19)
Rhode Island (38)
South America (1216)
South Carolina (47)
South Dakota (1)
Southern California (3420)
Tennessee (134)
Texas (1388)
United States (31952)
Utah (258)
Virginia (223)
Washington D.C. (70)
Washington State (765)
West Virginia (4)
Wisconsin (77)
Wyoming (2)
661,284 Results for "kuros biosciences formally known as cytos biotech merged with kuros biosurgery".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Kuros Biosciences announces changes in the Board of Directors
September 4, 2025
·
3 min read
Press Releases
Kuros Biosciences Reports First Half of 2025 Results
August 14, 2025
·
12 min read
Press Releases
Kuros Biosciences increases the annual guidance for 2025, The company reports 77% year-over-year increase for the first nine months of 2025
October 16, 2025
·
7 min read
Press Releases
Kuros Biosciences launches MagnetOs MIS Delivery System by completing first cases, and continues global expansion with incremental Brazil clearance
August 5, 2025
·
6 min read
Annual General Meeting of Kuros Biosciences Approves All Resolutions
Kuros Biosciences (SIX:KURN), a leader in next generation bone graft technologies, held its Annual General Meeting today.
April 17, 2024
·
2 min read
Press Releases
Kuros Biosciences to share latest MagnetOs™ market impact and strategic priorities at Capital Market Day in Zürich
May 13, 2025
·
5 min read
Press Releases
Kuros Biosciences grows sales to CHF 75.6 million for 2024
March 11, 2025
·
10 min read
Press Releases
Kuros Biosciences reports 82% year over year increase in sales in the first three months of 2025
April 15, 2025
·
7 min read
Press Releases
Kuros Biosciences Expands into Extremities Markets
November 19, 2024
·
5 min read
Kuros Biosciences Receives FDA Clearance for Use of MagnetOs in Interbody Spinal Cages
Kuros Biosciences (“Kuros” or the “Company”), a leader in next generation bone graft technologies, announced today that MagnetOs Flex Matrix has been cleared for use in the interbody space by the U.S. Food and Drug Administration (FDA).
November 28, 2023
·
5 min read
1 of 66,129
Next
